Transitions launches Vantage lens and dedicated educational resource site

Article

Transitions Optical has launched its Transitions Vantage lenses, which darken and polarize on exposure to ultraviolet light, according to a recent announcement from the company.

Pinellas Park, FL - Transitions Optical has launched its Transitions Vantage lenses, which darken and polarize on exposure to ultraviolet light, according to a recent announcement from the company.

Transitions also established a Web site [www.transitionsvantage.com] designed to help professionals better understand the product and how to recommend it to patients.

“Education has always been a critical component to successfully introducing a new product in our industry,” said Alexis Cardona, chief marketing officer, Transitions Optical.  “This time, we've not only expanded our family of products with Transitions Vantage lenses but we've also introduced a completely new technology, variable polarization, to the industry making proper education even more critical. By offering a central resource for information, we hope to make it easy for our partners to understand this new technology and how it can offer patients a completely new benefit.”

Eye-care professionals who visit the site can access product information, instructional videos, educational tools and marketing materials. Upon completion of a short quiz, doctors can sign up to receive a complimentary launch kit, which includes a Transitions Vantage lens lorgnette sample, a glare simulator, consumer brochures, a recommendation guide, frequently asked questions, and a final inspection guide with film. 

Transitions Vantage lenses will officially become available to consumers on May 1 in a variety of materials and exclusively in gray.

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.